Get the latest creative news from FooBar about art, design and business.
Reside updates: Shares in Eisai leap 9% on US approval of Alzheimer’s drug
A brand new Alzheimer’s drug created by Biogen and Eisai Co Ltd has proven promising outcomes.
Type above and press Enter to search. Press Esc to cancel.